One Calamos Global Total Return Fund (CGO) share class is reported fully under a BlackRock unit

BlackRock Portfolio Management LLC reports shared beneficial ownership of 360,000 Series H preferred shares of Calamos Global Total Return Fund (CGO), representing 100% of that class. The entity has shared voting and dispositive power over these shares, with no sole power. The filing was made under the Securities Exchange Act of 1934.

Original reporting
Published Sep 8, 2026, 8:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 6:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefRegulation
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$CGO
Relevance
6/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

Low
01

Why it matters

The disclosure provides transparency on ownership concentration, but does not indicate immediate operational changes.

02

Market read

A regulatory filing with limited trading relevance; mainly of interest to fund shareholders and compliance analysts.

03

What to watch

Potential tax or regulatory implications for BlackRock's broader portfolio.

Relevance 6/10Novelty 6/10Timing: filing date 08/31/2026

Background

Schedule 13G filing reveals BlackRock Portfolio Management LLC beneficially owns 100% of CGO Series H preferred shares.

Market effects

Highlights BlackRock's full control of CGO Series H preferred shares, may affect fund governance perception.

Limited to investors in the fund and related insurance entities.

Minimal; primarily a disclosure for transparency.

Counterpoint

The full ownership may not materially change fund performance, so market impact could be negligible.

Key entities

  • BlackRock Portfolio Management LLC

    BlackRock-affiliated entity reporting 100% ownership of CGO Series H preferred shares.

  • Calamos Global Total Return Fund

    Issuer of the Series H Mandatory Redeemable Preferred Shares.

Related articles

$CGOMed

Canada’s Cogeco Reports $1.8 Billion Loss

Cogeco (TSE: CGO) reported a fiscal Q3 loss of $1.8 billion versus a $74 million profit a year earlier, driven mainly by a $1.7 billion impairment charge tied to its U.S. telecom business, according to the company. Revenue fell to $724.2 million from $758.5 million. Loss per share was $42.84 versus EPS of $2.13.

$CGOMed

Cogeco announces its Q3 2026 financial results

Cogeco Inc. (TSX: CGO) reported Q3 fiscal 2026 results for the quarter ended May 31, 2026. Revenue fell 4.5% to $724.2M and adjusted EBITDA fell 2.9% to $357.0M, though Canadian telecom adjusted EBITDA rose 3.9%. The company recorded $2.2B non-cash impairment charges in U.S. telecom. Free cash flow rose 15.7% to $170.7M. It also declared a quarterly dividend of $0.987 per share.

$CGOMedAI 8/10

Cogeco reports Q3 loss amid 'significant turbulence' for U.S. telecom sector

Cogeco Inc. (TSX:CGO) reported a Q3 loss of $1.8 billion, or diluted loss of $42.84 per share, versus a year-ago profit of $74 million. The company attributed the loss mainly to $2.2 billion in non-cash pre-tax impairment charges in its U.S. telecom segment. U.S. telecom revenue fell 10% and Cogeco cited competitive pricing and subscriber shifts; overall revenue was $724.2 million.

$CGOMed

Cogeco Q3 Earnings Call Highlights

Cogeco Inc. (TSE:CGO) discussed Q3 results on an earnings call. Management said U.S. cable faces “significant turbulence” and recorded a non-cash U.S. impairment of CAD 1.8B ($1.3B) goodwill plus a CAD 26M pretax intangible impairment. It expects weaker U.S. Q4 revenue and adjusted EBITDA, with a material rise in customer losses, while citing wireless, Welo and AI as improvement levers.

$ABTLowAI 8/10

Sunday Edition: Sodium

Abbott Laboratories agreed to pay $384.9M to settle a DOJ case over a 2022 infant formula outbreak. The settlement doesn't determine liability. Pending lawsuits remain. No specific company was named in an E. coli and Salmonella outbreak linked to seed supplier Everything Sprouts LLC. Italy's hepatitis A outbreak affected 130 people, possibly from bivalve mollusks. UK small businesses show good food safety practices but low awareness of food crime.